• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受直接经皮冠状动脉血运重建术的 ST 段抬高型心肌梗死患者中,血栓负荷的定量分析作为术中无复流的独立预测因子。

Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.

机构信息

National Institute of Cardiovascular Diseases, Karachi, Pakistan.

Karachi Medical and Dental College, Karachi, Pakistan.

出版信息

J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):288-294. doi: 10.55519/JAMC-02-9698.

DOI:10.55519/JAMC-02-9698
PMID:35576288
Abstract

BACKGROUND

Aim of this study was to perform quantitative evaluation of high thrombus burden (Grade ≥4) as an independent predictor of slow/no reflow phenomenon during primary percutaneous coronary interventions (PCI) of patients with ST-segment elevation myocardial infarction (STEMI).

METHODS

In this analytical cross-sectional study we included consecutive patients who have undergone primary PCI for STEMI at a tertiary care cardiac center of the Pakistan. High thrombus burden was defined as angiographic thrombus grade ≥4. The thrombolysis in myocardial infarction (TIMI) flow rate < III was defined as slow/no reflow phenomenon. Results of multivariate logistic regression analysis for slow/no reflow phenomenon were reported as odds ratio (OR).

RESULTS

This analysis included 747 patients, 78.2% (584) patients were male and mean age was 55.82±11.54 years. High thrombus burden was observed in 68.1% (509) of the patients. Slow/no reflow phenomenon was observed in 33.6% (251) which was more common among patients in high thrombus burden group, 39.7% (202/509) vs. 20.6% (49/238); p<0.001. Adjusted OR of thrombus Grade ≥ 4 was 2.33 [1.6 -3.39]; p<0.001. Other significant variables were female gender (1.51 [1.01 -2.27]; p=0.045), left ventricular end-diastolic pressure (LVEDP) ≥20 mmHg (2.34 [1.69 -3.26]; p<0.001), total lesion length ≥20 cm (1.54 [1.09-2.16]; p=0.014), and neutrophil count ≥8.8 cells/μL (1.72 [1.22 -2.43]; p=0.002).

CONCLUSIONS

High thrombus burden (Grade ≥4) is a significant and an independent predictor of the slow/no reflow phenomenon. While predicting slow/no reflow phenomenon, thrombus burden should be given due importance along with other significant factors such as gender, LVEDP, lesion length, and neutrophil counts.

摘要

背景

本研究旨在对高血栓负荷(等级≥4)作为 ST 段抬高型心肌梗死(STEMI)患者直接经皮冠状动脉介入治疗(PCI)中慢血流/无复流现象的独立预测因子进行定量评估。

方法

在这项分析性横断面研究中,我们纳入了在巴基斯坦一家三级心脏中心接受直接 PCI 治疗的 STEMI 连续患者。高血栓负荷定义为血管造影血栓分级≥4。心肌梗死溶栓(TIMI)血流< III 级定义为慢血流/无复流现象。慢血流/无复流现象的多变量逻辑回归分析结果以比值比(OR)报告。

结果

本分析纳入了 747 名患者,其中 78.2%(584 名)为男性,平均年龄为 55.82±11.54 岁。68.1%(509 名)的患者存在高血栓负荷。33.6%(251 名)出现慢血流/无复流现象,在高血栓负荷组中更为常见,占 39.7%(202/509)比 20.6%(49/238);p<0.001。血栓分级≥4 的调整 OR 为 2.33 [1.6-3.39];p<0.001。其他显著变量包括女性(1.51 [1.01-2.27];p=0.045)、左心室舒张末期压(LVEDP)≥20mmHg(2.34 [1.69-3.26];p<0.001)、总病变长度≥20cm(1.54 [1.09-2.16];p=0.014)和中性粒细胞计数≥8.8 个/μL(1.72 [1.22-2.43];p=0.002)。

结论

高血栓负荷(等级≥4)是慢血流/无复流现象的一个显著且独立的预测因子。在预测慢血流/无复流现象时,除其他重要因素(如性别、LVEDP、病变长度和中性粒细胞计数)外,还应重视血栓负荷。

相似文献

1
Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.在接受直接经皮冠状动脉血运重建术的 ST 段抬高型心肌梗死患者中,血栓负荷的定量分析作为术中无复流的独立预测因子。
J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):288-294. doi: 10.55519/JAMC-02-9698.
2
Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死无复流现象的预测因素。
Ann Cardiol Angeiol (Paris). 2021 Jun;70(3):136-142. doi: 10.1016/j.ancard.2021.04.004. Epub 2021 May 4.
3
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.入院时红细胞分布宽度-血小板比值对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者无复流现象的预测价值
Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.
4
The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.初始和残余血栓负荷对ST段抬高型心肌梗死患者无复流现象的影响。
Coron Artery Dis. 2015 May;26(3):245-53. doi: 10.1097/MCA.0000000000000197.
5
Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST Segment Resolution After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction With Initial Thrombolysis in Myocardial Infarction Grade 0.在初始心肌梗死溶栓分级为0级的ST段抬高型心肌梗死患者中,肾功能不全作为经皮冠状动脉介入治疗后慢血流/无复流现象及ST段回落受损的预测指标。
Circ J. 2021 Sep 24;85(10):1770-1778. doi: 10.1253/circj.CJ-21-0221. Epub 2021 Jul 20.
6
Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,高岭土诱导的最大幅度与慢血流/无复流的关系。
Int J Cardiol. 2022 Dec 15;369:13-18. doi: 10.1016/j.ijcard.2022.08.025. Epub 2022 Aug 12.
7
The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时血清类风湿因子水平与无复流现象的关系
J Clin Lab Anal. 2018 Nov;32(9):e22598. doi: 10.1002/jcla.22598. Epub 2018 Jun 26.
8
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.纤维蛋白原与白蛋白比值对预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流及短期预后的价值
Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16.
9
[Deferred versus immediate stenting in patients with ST - segment elevation myocardial infarction and residual large thrombus burden reclassified in the culprit lesion].ST段抬高型心肌梗死且罪犯病变中残留大量血栓负荷患者的延迟支架置入与即刻支架置入对比研究(重新分类)
Arch Cardiol Mex. 2018 Dec;88(5):432-440. doi: 10.1016/j.acmx.2018.03.002. Epub 2018 Apr 26.
10
Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后无复流现象的新预测因子及不良长期预后。
Indian Heart J. 2021 Jan-Feb;73(1):35-43. doi: 10.1016/j.ihj.2020.12.008. Epub 2020 Dec 29.

引用本文的文献

1
Prognosticating short-term outcomes in patients with STEMI-ACS and intra-procedural slow-flow/no-reflow phenomenon.预测ST段抬高型急性冠脉综合征(STEMI-ACS)患者的短期预后及术中慢血流/无复流现象。
Herz. 2025 Aug 14. doi: 10.1007/s00059-025-05326-w.
2
A Machine Learning Model for the Prediction of No-Reflow Phenomenon in Acute Myocardial Infarction Using the CALLY Index.一种使用CALLY指数预测急性心肌梗死无复流现象的机器学习模型。
Diagnostics (Basel). 2024 Dec 14;14(24):2813. doi: 10.3390/diagnostics14242813.
3
Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials.
急性心肌梗死伴ST段抬高患者冠状动脉内注射重组人尿激酶原的安全性和有效性:一项随机对照试验的荟萃分析
Exp Ther Med. 2022 Nov 30;25(1):40. doi: 10.3892/etm.2022.11739. eCollection 2023 Jan.